Multiple endocrine neoplasia - Introduction

Journal of Internal Medicine

Volumn 257, Issue 1, 2005, Pages 2-5

  Marx, Stephen J ^a,c   Stratakis, C A ^b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Carney Complex; Cyclic AMP; Genetic counselling; HRPT2; Hyperparathyroid; MEN1; MEN2; Multiple endocrine neoplasia; PRKAR1A; Tumorigenesis; VHL

Indexed keywords

CALCIMIMETIC AGENT; PROTEIN TYROSINE KINASE INHIBITOR;

CARCINOGENESIS; CLINICAL FEATURE; CLINICAL PRACTICE; CONFERENCE PAPER; DRUG INDICATION; GENE LOCUS; GENE SEQUENCE; GENETIC COUNSELING; GENOTYPE PHENOTYPE CORRELATION; HORMONE RELEASE; MEN1 GENE; MULTIPLE ENDOCRINE NEOPLASIA; ONCOGENE; PEDIGREE; PRIORITY JOURNAL; RET GENE; SYMPOSIUM; TUMOR SUPPRESSOR GENE;

GENOTYPE; HUMANS; HYPERPARATHYROIDISM; MULTIPLE ENDOCRINE NEOPLASIA; MUTATION; PATIENT CARE TEAM; PHENOTYPE;

EID: 12344317822     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2004.01419.x     Document Type: Conference Paper

References (13)

1. Wermer P. Genetic aspects of adenomatosis of endocrine glands. Am J Med 1954; 16: 363-71.
2. Carrasco CA, Gonzalez AA, Carvajal CA et al. Novel intronic mutation of MEN1 gene causing familial isolated primary hyperparathyroidism. J Clin Endocrinol Metab 2004; 89: 4124-9.
3. Marx SJ. Contrasting paradigms for hereditary hyperfunction of endocrine cells. J Clin Endocrinol Metab 1999; 84: 3001-9.
4. Knudson AG. Two genetic hits (more or less) to cancer. Nat Rev Cancer 2001; 1: 157-62.
5. Noble ME, Endicott JA, Johnson LN. Protein kinase inhibitors: insights into drug design from structure. Science 2004; 303: 1800-5.
6. Griffin KJ, Kirschner LS, Matyakhina L et al. Down-regulation of regulatory subunit type 1A of protein kinase A leads to endocrine and other tumors. Cancer Res 2004 (in press).
7. Bilezikian JP, Brandi ML, Rubin M, Silverberg SJ. Primary hyperparathyroidism: New concepts in clinical, densitometric, and biochemical features. J Intern Med 2005; 257: 6-17.
8. Bradley KJ, Hobbs MR, Buley ID et al. Uterine tumours are a phenotypic manifestation of the hyperparathyroidism-jaw tumour (HPT-JT) syndrome. J Intern Med 2005; 257: 18-26.
9. Carling T, Udelsman R. Parathyroid surgery in familial hyperparathyroid disorders. J Intern Med 2005; 257: 27-37.
10. Machens A, Ukkat J, Brauckhoff M, Gimm O, Dralle H. Advances in the management of hereditary medullary thyroid cancer. J Intern Med 2005; 257: 50-9.
11. Tonelli F, Gratini G, Falchetti A, Nesi G, Brandi ML. Surgery for gastroenteropancreatic tumours in multiple endocrine neoplasia type 1: review and personal experience. J Intern Med 2005; 257: 38-49.
12. Pacak K, Ilias I, Adams KT, Eisenhofer G. Biochemical diagnosis, localization, and management of pheochromocytoma: focus on multiple endocrine neoplasia type 2 in relation to other hereditary syndromes and sporadic forms of the tumour. J Intern Med 2005; 257: 60-8.
13. Lips CJ, Höppener JW, Van Nesselrooij BP, Van der Luijt RB. Counselling in multiple endocrine neoplasia syndromes: from individual experience to general guidelines. J Intern Med 2005; 257: 69-77.